CDC Global AIDS Program International Laboratory Branch : building sustainable integrated laboratory capacity in PEPFAR countries
Corporate Authors:Centers for Disease Control and Prevention (U.S.). Global AIDS Program. International Laboratory Branch. ; United States. President's Emergency Plan for AIDS Relief. ;
Keywords:Acquired Immunodeficiency Syndrome/prevention & Control
Centers For Disease Control And Prevention (U.S.). Global AIDS Program. International Laboratory Branch.
Clinical Laboratory Services
Health Plan Implementation
HIV Infection/prevention & Control
United States. President's Emergency Plan For AIDS Relief.
Description:Introduction -- Office of the Branch Chief -- Serology/incidence and diagnostic team -- Molecular monitoring team -- Clinical and opportunistic infections monitoring team -- Systems strengthening team.
The Global AIDS Program (GAP), through the President’s Emergency Plan for AIDS Relief (PEPFAR), supports over 70 countries, bringing to bear the technical expertise gained from CDC’s more than 60 year history as the premier U.S. agency for disease control and prevention. CDC’s long-standing partnerships with Ministries of Health (MoH) assist with improvement of critical infrastructure and services to build sustainable national public health capacity.
In 2003, the United States Government (USG) launched PEPFAR, an interagency initiative to provide $15 billion over five years to fund care, treatment and prevention services in 15 countries that were hardest hit by the HIV/AIDS epidemic. Emergency rapid scale-up of HIV/AIDS prevention, care and treatment programs and developing laboratory infrastructure to support the services became the intense focus in resource-limited settings. On July 30, 2008, PEPFAR was reauthorized with a budget of up to $48 billion over five years to combat HIV/AIDS, tuberculosis, and malaria, with a continued emphasis on laboratory system strengthening and improved diagnostic laboratory capabilities.
Prior to PEPFAR, CDC strengthened laboratory infrastructure in host countries by using a “top-down” approach which concentrated on strengthening the national reference laboratory, or main laboratory in the host nation, and establishing partnerships with regional laboratories. With the inception of PEPFAR, CDC broadened its scope and began activities to improve capacity at all levels of a tiered laboratory system: national, provincial, district, and primary care. The activities helped PEPFAR to reach its initial set of ambitious goals: treatment for 2 million HIV-infected people, prevention of 7 million new infections, and care for 10 million people infected with, or affected by, HIV/AIDS. The new 10-year goals aim to increase the number of those treated to 3 million, the number of infections prevented to 12 million, and the number of people receiving care to 12 million.
Supporting Files:No Additional Files
You May Also Like: